Koers Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
REKA
IL0010810096
Farmaceutische producten
Omzet 2022 | 292 mln. 76,8 mln. 71,83 mln. | Omzet 2023 | 322 mln. 84,49 mln. 79,02 mln. | Marktkapitalisatie | 169 mln. 44,32 mln. 41,45 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -525K -491K | Nettowinst (verlies) 2023 | -6 mln. -1,58 mln. -1,47 mln. | EV/omzet 2022 | 1,1 x |
Nettoschuld 2022 | 145 mln. 38,2 mln. 35,72 mln. | Nettoschuld 2023 | 166 mln. 43,72 mln. 40,89 mln. | EV/omzet 2023 | 1,04 x |
K/w-verhouding 2022 |
-85,5
x | K/w-verhouding 2023 |
-24,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 17,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 80 | 24-08-93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01-11-18 |
Director/Board Member | 78 | 24-08-93 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-15 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,35% | 71,39 mld. | |
+2,39% | 25,1 mld. | |
+5,38% | 8,59 mld. | |
+6,69% | 8,19 mld. | |
-20,96% | 7,91 mld. | |
+0,49% | 4,54 mld. | |
+17,12% | 4,31 mld. | |
-3,38% | 3,93 mld. | |
-2,61% | 3,86 mld. |